Lundbeck
LDB.F
#2342
Rank
$4.81 B
Marketcap
$23.96
Share price
1.93%
Change (1 day)
-26.21%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (LDB.F)

Market cap: $4.81 Billion

As of May 2022 Lundbeck has a market cap of $4.81 Billion. This makes Lundbeck the world's 2342th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2022

Year Market cap Change
2022$4.80 B-6.02%
2021$5.10 B-25.51%
2020$6.85 B-9.51%
2019$7.57 B-12.78%
2018$8.68 B-13.61%
2017$10.05 B24.73%
2016$8.06 B18.52%
2015$6.80 B72.77%
2014$3.93 B-20.85%
2013$4.97 B72.61%
2012$2.88 B-41.39%
2011$4.91 B32.78%
2010$3.70 B1.41%
2009$3.65 B-18.48%
2008$4.48 B-17.97%
2007$5.46 B-5.3%
2006$5.76 B24.93%
2005$4.61 B

End of Day market cap according to different sources

On May 21st, 2022 the market cap of Lundbeck was reported to be:

$4.80 Billion
by Yahoo Finance
$4.80 Billion
by CompaniesMarketCap
$4.77 Billion
by Iex Cloud